Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo
Open Access
- 8 August 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-20
Abstract
Betulinic acid, a plant secondary metabolite, has gained significant attention due to its antiproliferative activity over a range of cancer cells. A promising betulinic acid analogue (2c) with better therapeutic efficacy than parent molecule to colon carcinoma cells has been reported. Despite impressive biological applications, low aqueous solubility and bioavailability create difficulties for its therapeutic applications. To overcome these lacunae and make it as a promising drug candidate we have encapsulated the lead betulinic acid derivative (2c) in a polymeric nanocarrier system (2c-NP) and evaluated its in vitro and in vivo therapeutic efficacy. Apoptosis that induces in vitro antiproliferative activity was significantly increased by 2c-NP compared to free-drug (2c), as assured by MTT assay, Annexin V positivity, JC1 analysis and cell cycle study. The therapeutic potential measured in vitro and in vivo reflects ability of 2c-NP as an effective therapeutic agent for treatment of colon carcinoma and future translation to clinical trials.Keywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology (DBT/RA/16/2016)
This publication has 58 references indexed in Scilit:
- The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticlesInternational Journal of Nanomedicine, 2012
- Morphological and Molecular Alterations in 1,2 Dimethylhydrazine and Azoxymethane Induced Colon Carcinogenesis in RatsBioMed Research International, 2010
- Betulinic acid, a natural compound with potent anticancer effectsAnti-Cancer Drugs, 2010
- Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse ModelGastroenterology, 2010
- Rational Design and Semisynthesis of Betulinic Acid Analogues as Potent Topoisomerase InhibitorsJournal of Natural Products, 2009
- Etoposide Loaded PLGA and PCL Nanoparticles II: Biodistribution and Pharmacokinetics after Radiolabeling with Tc-99mDrug Delivery, 2008
- Betulinic Acid and Its Derivatives, Potent DNA Topoisomerase II Inhibitors, from the Bark ofBischofia javanicaChemistry & Biodiversity, 2005
- Colorectal cancer: What the clinician wants to knowCancer Imaging, 2005
- Comparative toxicity of oleic acid and linoleic acid on Jurkat cellsClinical Nutrition, 2004
- Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV AgentsJournal of Medicinal Chemistry, 1996